There is one Phase I trial registered as NCT02637284 in 2015, intended to enrol forty-two participants, which was subsequently cancelled with no published results [7]
Dual and Triple Agonists: The next generation of medications, such as Tirzepatide (which targets both GLP-1 and GIP receptors), are already demonstrating even greater efficacy for weight loss and blood sugar control
One of the most important is Glutathione Peroxidase (GPx)
A5 : Generally safe, but consult a healthcare professional before combining different supplements or introducing new products
These essential nutrients combine to support and recycle glutathione in your body for sustained antioxidant power
17,18 In the authors experience, it is often possible to eliminate the sulfonylurea altogether, which can be advantageous in terms of avoiding hypoglycemia, minimizing the complexity of the diabetes regimen, and augmenting the weight loss benefits of the GLP-1 RA